Tocilizumab administration in a refractory case of COVID-19
Farzaneh Dastan, Seyed Alireza Nadji, Ali Saffaei, Payam Tabarsi
Topics & Concepts
TocilizumabCytokine release syndromePathophysiologyMedicineImmune systemRefractory (planetary science)CytokineCoronavirus disease 2019 (COVID-19)ImmunologyPneumoniaInterleukin 6Internal medicineT cellBiologyDiseaseRheumatoid arthritisInfectious disease (medical specialty)AstrobiologyChimeric antigen receptorCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research